• Users Online:669
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents  
DRUG PROVING
Year : 2008  |  Volume : 2  |  Issue : 4  |  Page : 20-25

Paraffin: A Multicentric double blind Homoeopathic Pathogenetic Trial carried out by CCRH


1 Research officer (H), CCRH Headquarters, New Delhi, India
2 Research officer (H), Drug Proving Research Unit, Kolkata, West Bengal, India
3 Research officer (H), Drug Proving Research Unit, Midnapore, West Bengal, India
4 Research officer (H), Drug Proving Research Unit, Ghaziabad, Uttar Pradesh, India
5 Senior Research Fellow, CCRH Headquarters, New Delhi, India

Date of Web Publication14-Apr-2014

Correspondence Address:
Rajpal
Central Council For Research In Homoeopathy, 61-65, Institutional Area, D-Block, Janakpuri, New Delhi - 110058
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions
  Abstract 

Objective: Objective of the study was to elicit the pharmacodynamic response of the drug Paraffin on healthy human volunteers in non-toxic doses.
Methodology: Drug was proved through a double-blind method and multi-centric study. Trial drug was proved in three potencies (6C, 30C and 200C) on 43 volunteers who were declared apparently healthy during their pre-trial medical examination by medical specialists. The volunteers consumed 56 doses (four doses per day for fourteen days) of each potency (6C, 30C and 200C) in three stages for a varying period. The symptoms generated during the trial period were noted by the volunteers and elaborated and cross examined by the Proving Masters. The data obtained from different centers were compiled at proving-cum-data processing cell at CCRH headquarters after de-coding.
Observation: Out of the 30 provers who were on actual drug trial, 13 manifested symptoms. Drug was able to produce symptoms in each potency more or less on every part of the body. Only a few symptoms appeared in more than one prover. Some of the symptoms have been reproved which are mentioned in the fragmentary provings published in different literature.
Conclusion: Pharmacodynamic response is elicited from every part of the body. Symptoms appeared (new and reproved) during the proving trial will add to the literature available on the drug and benefit the research scholars and clinicians. The symptoms need to be verified through clinical application in different clinical conditions.

Keywords: homoeopathy; pharmacodynamic effects; homoeopathic pathogenetic trial; drug proving; paraffin


How to cite this article:
Rajpal, Siddiqui V A, Dey N R, Das K C, Rai Y, Singh VK. Paraffin: A Multicentric double blind Homoeopathic Pathogenetic Trial carried out by CCRH. Indian J Res Homoeopathy 2008;2:20-5

How to cite this URL:
Rajpal, Siddiqui V A, Dey N R, Das K C, Rai Y, Singh VK. Paraffin: A Multicentric double blind Homoeopathic Pathogenetic Trial carried out by CCRH. Indian J Res Homoeopathy [serial online] 2008 [cited 2019 Dec 12];2:20-5. Available from: http://www.ijrh.org/text.asp?2008/2/4/20/130653

.




 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
   Abstract

 Article Access Statistics
    Viewed1034    
    Printed58    
    Emailed0    
    PDF Downloaded199    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]